GSK (LSE:GSK) and Alector have discontinued their phase 2 trial of an Alzheimer's drug candidate after the study did not meet ...
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround ...
In the first quarter of 2026, Moderna reported revenue of US$389 million versus US$108 million a year earlier, while net loss ...
A new CSIS analysis warns that U.S. withdrawal from key global immunization partnerships and rising vaccine skepticism could undermine disease prevention worldwide. For travelers to destinations like ...
Utah has become the measles center of the U.S. thanks to declining vaccination rates. Is there anything that can be done to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results